727 filings
Page 11 of 37
UPLOAD
bz7m8
26 Sep 22
Letter from SEC
12:00am
425
eods8n e1jy7mv
23 Sep 22
Business combination disclosure
8:01am
8-K
n9brlkj px1
23 Sep 22
Regulation FD Disclosure
8:00am
425
hdoac
14 Sep 22
Business combination disclosure
4:04pm
8-K
vn84zgssaag
14 Sep 22
Kineta CSO Thierry Guillaudeux Invited to Participate at the 2nd Annual VISTA Virtual Symposium
4:01pm
425
ilowk00 35y2
12 Sep 22
Business combination disclosure
4:01pm
8-K
6sq7f8p23a0m0
12 Sep 22
Kineta Announces Participation in the H.C. Wainwright 24th Annual Global Healthcare Conference
4:00pm
425
5jlpyt7e3je 99vz1
29 Aug 22
Business combination disclosure
4:03pm
8-K
faniy8ziep
29 Aug 22
Yumanity Therapeutics Announces Filing of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with Kineta
4:01pm
8-K
ehwp1 1cwp
4 Aug 22
Yumanity Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Developments
4:51pm
425
h1n4bge918wz7v
20 Jul 22
Business combination disclosure
6:09am
8-K
92pl1yk
20 Jul 22
Regulation FD Disclosure
6:07am
4
gx0hj0xudzzc
6 Jul 22
YUMANITY THERAPEUTICS / Richard Peters ownership change
4:54pm
425
i8r19 jl1h0bcw1d
28 Jun 22
Business combination disclosure
4:03pm
8-K
rdtwk42
28 Jun 22
Kineta Announces Appointment of Thierry Guillaudeux, PhD to Chief Scientific Officer
4:02pm
425
x9z6igip
17 Jun 22
Business combination disclosure
4:03pm
8-K
yqd65pte3w5t
17 Jun 22
Kineta Presents New Preclinical Data and Phase 1/2 Clinical Trial Design of KVA12.1 at the Tumor Myeloid-Directed Therapies Summit
4:02pm
8-K
65n7q0ptg55nzhy6
9 Jun 22
Submission of Matters to a Vote of Security Holders
4:06pm